R&D Changing Faces – Pharma and biotech September 2024 Welcome to the September edition of Changing Faces.
R&D Changing Faces: Pharma and biotech hires for August 2024 Welcome to the August edition of Changing Faces for the pharma and biotech sectors.
R&D Changing Faces – Pharma and Biotech July 2024 We’re back on track this month with Changing Faces as we look back at the month in pharma and biotech hires and – especially this month – departures.
R&D Changing Faces – Pharma and biotech May and June 2024 Welcome back to another edition of Changing Faces.
R&D Changing Faces: Pharma and biotech hires from April 2024 Coming to you well over a month late, we still want to acknowledge the many comings and goings we saw in the biotech industry in April.
R&D Changing Faces: Pharma and biotech hires from March 2024 Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
